InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: misiu143 post# 157752

Thursday, 04/08/2021 11:12:27 PM

Thursday, April 08, 2021 11:12:27 PM

Post# of 232889
Thank you for this enlightening response. Much respect for all the knowledge you share with us here.
I was not joking and it was a reason I think Sanofi a traditionally large vaccine supplier should want to partner with CytoDyn to try its vaccinevyhat failed with the GlaxoSmithKline adjuvant as they are still trying new things to try to further develop this vaccine. This fits with what Dr Kelly said about BPs wanting to do trials with Leronlimab and a vaccine adjuvant is absolutely not something CytoDyn could do on its own. Using Leronlimab in vaccine trials is the most logical next step BUT it absolutely needs to be done by a BP already well into the development of the vaccine.
Sanofi or Merck who's vaccine also failed so far.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News